{"id":36958,"date":"2026-02-11T10:05:21","date_gmt":"2026-02-11T10:05:21","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/global-therapeutic-vaccines-market-industry-mordor\/"},"modified":"2026-09-11T03:51:52","modified_gmt":"2026-09-10T18:51:52","slug":"global-therapeutic-vaccines-market-industry-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/global-therapeutic-vaccines-market-industry-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026 &#8211; 2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/global-therapeutic-vaccines-market-industry_1663336164721_Therapeutic_vaccines_market_players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/global-therapeutic-vaccines-market-industry-size-image-1767015640673.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \uc5f0\uad6c \ubc94\uc704<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \uc2dc\uc7a5 \ub3d9\ud5a5<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \uc2dc\uc7a5 \uac1c\uc694<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \uc2dc\uc7a5 \ub3d9\uc778<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \ub9cc\uc131 \ubc0f \uac10\uc5fc\uc131 \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \ubc31\uc2e0 R&amp;D\uc5d0 \ub300\ud55c \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 \uac15\ud654<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \uc885\uc591 \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc81c\uc57d\/\ubc14\uc774\uc624 \uae30\uc220 \uae09\uc99d<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 \ud68d\uae30\uc801\uc778 mRNA \uae30\ubc18 \uce58\ub8cc \ubc31\uc2e0 \uc2b9\uc778<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 AI \uae30\ubc18 \uc2e0\ud56d\uc6d0 \ubc1c\uacac\uc744 \ud1b5\ud55c \uac1c\uc778\ud654 \uac00\uc18d\ud654<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 \ud604\uc7a5 \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \ubaa8\ub378<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \uc2dc\uc7a5 \uc81c\uc57d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \uc790\ubcf8 \uc9d1\uc57d\uc801\uc774\uace0 \uace0\uc704\ud5d8 \uc784\uc0c1 \uac1c\ubc1c \uc8fc\uae30<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \uc5c4\uaca9\ud55c \ub2e4\uc911 \uad00\ud560 \uaddc\uc81c \uc7a5\uc560\ubb3c<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 GMP \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\/\ud50c\ub77c\uc2a4\ubbf8\ub4dc \uc81c\uc870 \uc5ed\ub7c9 \ubd80\uc871<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \ud6c4\uae30 I-O \uc784\uc0c1 \uc2e4\ud328\ub85c \uc778\ud55c \ud22c\uc790 \uc2ec\ub9ac \uc704\ucd95<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \uaddc\uc81c \ud658\uacbd<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \uc81c\ud488\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \uc790\uac00\uba74\uc5ed \uc9c8\ud658 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \uc2e0\uacbd \uc9c8\ud658 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \uc554 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \uac10\uc5fc\uc131 \uc9c8\ud658 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 \uae30\ud0c0 \uc81c\ud488<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \uae30\uc220\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \ub3d9\uc885 \ubc31\uc2e0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \uc790\uac00 \ubc31\uc2e0<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \uc5f0\ub839\ub300\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \uc131\uc778<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \uc18c\uc544<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \ub178\uc778<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \uc720\ud1b5 \ucc44\ub110\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \uacf5\uacf5<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \ubbfc\uac04<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \uc9c0\uc5ed\ubcc4<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \ubd81\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \ubbf8\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \uce90\ub098\ub2e4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \uba55\uc2dc\ucf54<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \uc720\ub7fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \ub3c5\uc77c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \uc601\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \ud504\ub791\uc2a4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \uc2a4\ud398\uc778<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \uc911\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \uc77c\ubcf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \uc778\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \ud638\uc8fc<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \ub0a8\ubbf8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \ube0c\ub77c\uc9c8<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \ud68c\uc0ac \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc0ac\uc6a9 \uac00\ub2a5\ud55c \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.3.1 Agenus Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.2 Argos Therapeutics Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.3 Celldex Therapeutics Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.4 Dendreon Corp.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.5 GlaxoSmithKline plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.6 Merck &amp; Co., Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.7 Novartis AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.8 Pfizer Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.9 Phio Pharmaceuticals Corp.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.10 Inovio Pharmaceuticals<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.11 AstraZeneca plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.12 BioNTech SE<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.13 Moderna, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.14 Sanofi SA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.15 Bavarian Nordic A\/S<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.16 Gilead Sciences (Kite Pharma)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.17 Takeda Pharmaceutical Co.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.18 CSL Seqirus<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.19 CureVac N.V.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.20 GeoVax Labs, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.21 Vaccitech plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.22 Nykode Therapeutics<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d \ubcf4\uace0\uc11c, 2031\ub144: \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5 \uaddc\ubaa8, \uc810\uc720\uc728, \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21\uc744 \uc0c1\uc138\ud788 \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc81c\ud488(\uc790\uac00\uba74\uc5ed \uc9c8\ud658 \ubc31\uc2e0, \uc554 \ubc31\uc2e0 \ub4f1), \uae30\uc220(\ub3d9\uc885 \ubc31\uc2e0, \uc790\uac00 \ubc31\uc2e0), \uc5f0\ub839\ub300(\uc131\uc778 \ub4f1), \uc720\ud1b5 \ucc44\ub110(\uacf5\uacf5, \ubbfc\uac04), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \uac00\uce58(USD) \uae30\uc900\uc73c\ub85c \uc608\uce21\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21<\/p>\n<p>\uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 2025\ub144 304.4\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 342.2\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \ucd94\uc815\ub418\uba70, 2031\ub144\uc5d0\ub294 614.8\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 12.43%\ub97c \uae30\ub85d\ud558\ub294 \ub192\uc740 \uc131\uc7a5\uc138\uc785\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc9c8\ubcd1 \uc608\ubc29 \uc911\uc2ec\uc5d0\uc11c \uc554 \ubc0f \ub9cc\uc131 \ubc14\uc774\ub7ec\uc2a4 \uac10\uc5fc\uacfc \uac19\uc740 \ud65c\uc131 \uc9c8\ud658 \uce58\ub8cc\uc5d0 \uc911\uc810\uc744 \ub454 \uba74\uc5ed\uce58\ub8cc \ud50c\ub7ab\ud3fc\uc73c\ub85c \uc804\ud658\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud68d\uae30\uc801\uc778 mRNA \ubc31\uc2e0 \uc2b9\uc778\uacfc AI \uae30\ubc18 \uc2e0\uc0dd\ud56d\uc6d0(neo-antigen) \ubc1c\uacac \uae30\uc220\uc740 \uac1c\ubc1c \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uace0 \uc784\uc0c1 \uc815\ud655\ub3c4\ub97c \ud5a5\uc0c1\uc2dc\ud0a4\uba70, \ud22c\uc790\uc790 \uc2e0\ub8b0\ub97c \ub192\uc774\uace0 \uaddc\uc81c \ub2f9\uad6d\uc758 \uc2e0\uc18d \uc2b9\uc778 \uacbd\ub85c\ub97c \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud32c\ub370\ubbf9 \uae30\uac04 \ub3d9\uc548 \ud655\ubcf4\ub41c \uc81c\uc870 \uc5ed\ub7c9\uc740 \uc0c8\ub85c\uc6b4 \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc2e0\uc18d\ud55c \ud655\uc7a5\uc744 \uc9c0\uc6d0\ud558\uba70, Project NextGen\uacfc \uac19\uc740 \uc815\ubd80 \ud504\ub85c\uadf8\ub7a8\uc740 \ucd08\uae30 \ub2e8\uacc4\uc758 \uc704\ud5d8\uc744 \uc904\uc774\ub294 \ube44\ud76c\uc11d\uc131 \uc790\ubcf8\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. R&#038;D, \uc784\uc0c1 \uc81c\uc870, \ucf5c\ub4dc\uccb4\uc778 \uc720\ud1b5\uc744 \ud1b5\ud569\ud558\uc5ec \ub2e4\uc591\ud55c \uc801\uc751\uc99d\uc5d0 \uac78\uccd0 \ubaa8\ub4c8\ud615 \uac1c\uc778 \ub9de\ucda4\ud615 \uce58\ub8cc\ubc95\uc744 \ub354 \ube60\ub974\uac8c \ucd9c\uc2dc\ud558\ub294 \uae30\uc5c5\ub4e4\uc774 \uacbd\uc7c1 \uc6b0\uc704\ub97c \ud655\ubcf4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc9c0\ud45c (2026-2031):<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8 (2026\ub144): 342.2\uc5b5 \ub2ec\ub7ec<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8 (2031\ub144): 614.8\uc5b5 \ub2ec\ub7ec<br \/>\n*   \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960 (CAGR): 12.43%<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p>2. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778<\/p>\n<p>2.1. \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n*   \ub9cc\uc131 \ubc0f \uac10\uc5fc\uc131 \uc9c8\ud658 \uc720\ubcd1\ub960 \uc99d\uac00 (+2.1% CAGR \uc601\ud5a5): \uc804 \uc138\uacc4\uc801\uc778 \uace0\ub839\ud654\ub294 \uc554 \ubc1c\ubcd1\ub960\uc744 \ub192\uc774\uace0, \uc9c4\ud654\ud558\ub294 \ubcd1\uc6d0\uade0\uc740 \ubc14\uc774\ub7ec\uc2a4 \ubc0f \uc138\uade0\uc131 \uc9c8\ud658 \ubd80\ub2f4\uc744 \uc9c0\uc18d\uc2dc\ud0b5\ub2c8\ub2e4. \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc740 \uba74\uc5ed \uccb4\uacc4\ub97c \ud6c8\ub828\uc2dc\ucf1c \uae30\uc874 \uc9c8\ubcd1\uacfc \uc2f8\uc6b0\uac8c \ud568\uc73c\ub85c\uc368 \uc774\ub7ec\ud55c \ubbf8\ucda9\uc871 \uc218\uc694\ub97c \ud574\uacb0\ud569\ub2c8\ub2e4. \uc554, \ub9cc\uc131 B\ud615 \uac04\uc5fc, \uc7ac\ubc1c\uc131 \uc0dd\uc2dd\uae30 \ud3ec\uc9c4 \ub4f1\uc740 \ud3c9\uc0dd \uc57d\ubb3c \uce58\ub8cc\ub97c \uc904\uc774\ub294 \uc9c0\uc18d\uc801\uc778 \ubc18\uc751\uc744 \uc81c\uacf5\ud558\ub294 \uc8fc\uc694 \ub300\uc0c1\uc785\ub2c8\ub2e4. \uacf5\uc911 \ubcf4\uac74 \ub2f9\uad6d\uc740 \uce58\ub8cc \uc694\ubc95\uc744 \ub9cc\uc131 \uc57d\ubb3c\uc5d0 \ub300\ud55c \uc608\uc0b0 \uce5c\ud654\uc801\uc778 \ub300\uc548\uc73c\ub85c \ubcf4\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \ud655\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \ubc31\uc2e0 R&#038;D\uc5d0 \ub300\ud55c \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 \uac15\ud654 (+1.8% CAGR \uc601\ud5a5): \ubbf8\uad6d\uc740 \uc608\ubc29\uc744 \ub118\uc5b4 \uce58\ub8cc\uc6a9 \uc560\ud50c\ub9ac\ucf00\uc774\uc158\uc744 \ud3ec\ud568\ud55c \ucc28\uc138\ub300 \ud50c\ub7ab\ud3fc\uc5d0 50\uc5b5 \ub2ec\ub7ec\ub97c \ubc30\uc815\ud55c Project NextGen\uc744 \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4. BARDA\uc758 \ub9c8\uc77c\uc2a4\ud1a4 \uae30\ubc18 \uc9c0\uc6d0\uc740 \ud32c\ub370\ubbf9 \ub300\uc751\uacfc \ub9cc\uc131 \uc9c8\ud658 \uce58\ub8cc \uc0ac\uc774\ub97c \uc804\ud658\ud560 \uc218 \uc788\ub294 \uc774\uc911 \uc6a9\ub3c4 \uae30\uc220\uc744 \uc6b0\uc120\uc2dc\ud558\uc5ec GMP \uad6c\ucd95\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc2a4\ucf00\uc77c\uc5c5 \uc704\ud5d8\uc744 \uc904\uc785\ub2c8\ub2e4. \uc720\uc0ac\ud55c \uc9c0\uc6d0\uc774 EU Horizon \ud504\ub808\uc784\uc6cc\ud06c\uc5d0\ub3c4 \ub098\ud0c0\ub098\uba70, CEPI\ub294 \ub2e4\uad6d\uac00 \uc2b9\uc778 \uae30\uac04\uc744 \ub2e8\ucd95\ud558\ub294 \uae00\ub85c\ubc8c \uc784\uc0c1 \uc2dc\ud5d8 \ud45c\uc900\ud654\ub97c \uc870\uc728\ud569\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc57d\/\ubc14\uc774\uc624\ud14d\uc758 \uc885\uc591\ud559 \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778 \uae09\uc99d (+1.5% CAGR \uc601\ud5a5): \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\ub294 \uba74\uc5ed \ub9e4\uac1c \uc554 \ud1b5\uc81c\uc758 \uac1c\ub150 \uc99d\uba85\uc744 \ud655\ub9bd\ud588\uc73c\uba70, \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc740 \uc774\ub7ec\ud55c \ubc18\uc751\uc744 \uc99d\ud3ed\uc2dc\ud0b5\ub2c8\ub2e4. \ubaa8\ub354\ub098\uc640 \uba38\ud06c\uc758 mRNA-4157\/\ud0a4\ud2b8\ub8e8\ub2e4 \ubcd1\uc6a9 \uc694\ubc95\uc740 2025\ub144 \ud751\uc0c9\uc885 3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \uc9c4\uc785\ud588\uc73c\uba70, \ud3d0\uc554 \ubc0f \ub300\uc7a5\uc554\uc73c\ub85c \uc801\uc6a9\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac \ud30c\ud2b8\ub108\uc2ed\uc740 \ud6c4\uae30 \ub2e8\uacc4 \uc790\uc6d0\uc744 \uc81c\uacf5\ud558\uace0, \ud50c\ub7ab\ud3fc \ubc14\uc774\uc624\ud14d \uae30\uc5c5\ub4e4\uc740 \uacf5\uc720 \ub77c\uc774\ube0c\ub7ec\ub9ac\uc5d0\uc11c \uc5ec\ub7ec \ud6c4\ubcf4 \ubb3c\uc9c8\uc744 \ubc18\ubcf5 \uac1c\ubc1c\ud558\uc5ec \uc790\uc0b0\ub2f9 \uc704\ud5d8\uc744 \ub0ae\ucda5\ub2c8\ub2e4.<br \/>\n*   \ud68d\uae30\uc801\uc778 mRNA \uae30\ubc18 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2b9\uc778 (+1.2% CAGR \uc601\ud5a5): 2025\ub144 \ucd5c\ucd08\uc758 mRNA \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc5d0 \ub300\ud55c FDA \uc2b9\uc778\uc740 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP) \uc804\ub2ec, \uba74\uc5ed\uc6d0\uc131 \ubc0f \uad00\ub9ac \uac00\ub2a5\ud55c \uc548\uc804\uc131 \ud504\ub85c\ud30c\uc77c\uc744 \uac80\uc99d\ud588\uc2b5\ub2c8\ub2e4. \ud32c\ub370\ubbf9 \uc2dc\ub300\uc758 \uc2dc\uc124\uc740 \uc774\uc81c \uc885\uc591\ud559 \ubc0f \ub9cc\uc131 \uac10\uc5fc \uc81c\ud488\uc73c\ub85c \uc804\ud658\ub418\uc5b4, \uc2e0\uaddc \ubc14\uc774\uc624\ub9ac\uc561\ud130\uc5d0 \ube44\ud574 \uc2dc\uc7a5 \ucd9c\uc2dc \uc2dc\uac04\uc744 \ub2e8\ucd95\ud569\ub2c8\ub2e4. mRNA\uc758 \ucf54\ub529 \uc720\uc5f0\uc131\uc740 \uc2e0\uc18d\ud55c \uac1c\uc778 \ub9de\ucda4\ud654\ub97c \uc9c0\uc6d0\ud558\uace0 \ud63c\ud569 \ubc0f \ub9e4\uce58 \uc870\ud569 \uc694\ubc95\uc744 \uc6a9\uc774\ud558\uac8c \ud558\uc5ec \ud658\uc790\ubcc4 \uacb0\uacfc\ub97c \uac1c\uc120\ud569\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \uc2e0\uc0dd\ud56d\uc6d0 \ubc1c\uacac\uc744 \ud1b5\ud55c \uac1c\uc778 \ub9de\ucda4\ud654 \uac00\uc18d\ud654 (+0.8% CAGR \uc601\ud5a5): AI \uae30\uc220\uc740 \uc2e0\uc0dd\ud56d\uc6d0 \ubc1c\uacac\uc744 \uac00\uc18d\ud654\ud558\uc5ec \uac1c\uc778 \ub9de\ucda4\ud615 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \ud604\uc7a5 \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \ubaa8\ub378 (+0.6% CAGR \uc601\ud5a5): \uac1c\ubc1c\ub41c \uc2dc\uc7a5\uc5d0\uc11c \ucd08\uae30 \ucc44\ud0dd\ub418\uace0 \uc788\ub294 \ud604\uc7a5 \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \ubaa8\ub378\uc740 \uc0dd\uc0b0 \ud6a8\uc728\uc131\uc744 \ub192\uc785\ub2c8\ub2e4.<\/p>\n<p>2.2. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n*   \uc790\ubcf8 \uc9d1\uc57d\uc801\uc774\uace0 \uace0\uc704\ud5d8\uc758 \uc784\uc0c1 \uac1c\ubc1c \uc8fc\uae30 (-1.9% CAGR \uc601\ud5a5): \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc740 \ud575\uc2ec \ub370\uc774\ud130\uac00 \ub098\uc624\uae30\uae4c\uc9c0 \uc218\ub144 \uac04 \uc218\ubc31\ub9cc \ub2ec\ub7ec\uc758 \ud22c\uc790\uac00 \ud544\uc694\ud569\ub2c8\ub2e4. \uc0dd\ubb3c\ud559\uc801 \uc81c\uc870\ub294 \uc2b9\uc778 \uc804\uc5d0 1\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc785\ud574\uc57c \ud558\ub294 \uacbd\uc6b0\uac00 \ub9ce\uc544 \ucd08\uae30 \ub2e8\uacc4 \uae30\uc5c5\uc758 \uc7ac\ubb34 \uc0c1\ud0dc\uc5d0 \ubd80\ub2f4\uc744 \uc90d\ub2c8\ub2e4. \uba74\uc5ed\ud559\uc801 \uac00\ubcc0\uc131\uc740 \uc18c\ubd84\uc790 \uc758\uc57d\ud488\ubcf4\ub2e4 \ud6c4\uae30 \ub2e8\uacc4\uc758 \uc2e4\ud328\uc728\uc744 \ub192\uc5ec \uac00\uce58 \ud3c9\uac00 \ubaa8\ub378\uc744 \ubcf5\uc7a1\ud558\uac8c \ud558\uace0 \uc2e0\uc911\ud55c \ud22c\uc790\ub97c \uc720\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc5c4\uaca9\ud55c \ub2e4\uc911 \uad00\ud560\uad8c \uaddc\uc81c \uc7a5\uc560\ubb3c (-1.3% CAGR \uc601\ud5a5): \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc740 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c, \uc138\ud3ec \uce58\ub8cc\uc81c \ubc0f \ubcf5\ud569 \uc81c\ud488 \ubc95\uaddc\uc758 \uad50\ucc28\uc810\uc5d0 \uc788\uc2b5\ub2c8\ub2e4. FDA \uc9c0\uce68\uc740 \uacc4\uc18d \uc9c4\ud654\ud558\uace0 \uc788\uc73c\uba70, EMA\ub294 \ubbf8\uad6d \uc694\uad6c \uc0ac\ud56d\uacfc \ub2e4\ub978 \ubcc4\ub3c4\uc758 \ucca8\ub2e8 \uce58\ub8cc\uc81c \uaddc\uc815\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4. \uae30\uc5c5\uc740 \uc885\uc885 \uac01 \uad00\ud560\uad8c\uc5d0 \ub300\ud574 \ud488\uc9c8 \uac10\uc0ac\ub97c \ubc18\ubcf5\ud574\uc57c \ud558\ubbc0\ub85c \uc2dc\uac04\uacfc \uaddc\uc815 \uc900\uc218 \ube44\uc6a9\uc774 \uc99d\uac00\ud569\ub2c8\ub2e4.<br \/>\n*   GMP \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\/\ud50c\ub77c\uc2a4\ubbf8\ub4dc \uc6a9\ub7c9 \ubd80\uc871 (-0.9% CAGR \uc601\ud5a5): GMP(Good Manufacturing Practice) \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc0f \ud50c\ub77c\uc2a4\ubbf8\ub4dc \uc0dd\uc0b0 \uc6a9\ub7c9 \ubd80\uc871\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc785\ub2c8\ub2e4.<br \/>\n*   \ud6c4\uae30 \ub2e8\uacc4 I-O \uc784\uc0c1 \uc2dc\ud5d8 \uc2e4\ud328\ub85c \uc778\ud55c \ud22c\uc790 \uc2ec\ub9ac \uc704\ucd95 (-0.7% CAGR \uc601\ud5a5): \ud6c4\uae30 \ub2e8\uacc4 \uba74\uc5ed-\uc885\uc591\ud559(I-O) \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uc2e4\ud328\ub294 \ud22c\uc790\uc790 \uc2ec\ub9ac\ub97c \uc704\ucd95\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>3.1. \uc81c\ud488\ubcc4: \uc554 \ubc31\uc2e0\uc774 \uc2dc\uc7a5 \ubcc0\ud654 \uc8fc\ub3c4<br \/>\n*   \uc554 \ubc31\uc2e0: 2025\ub144 129.8\uc5b5 \ub2ec\ub7ec(\uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc758 42.63%)\ub97c \uae30\ub85d\ud558\uba70 \uc0c1\uc5c5\uc801 \ucc44\ud0dd\uc758 \ud575\uc2ec\uc73c\ub85c \uc790\ub9ac \uc7a1\uc558\uc2b5\ub2c8\ub2e4. \uac80\uc99d\ub41c \ud56d\uc6d0, \uac15\ub825\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \uc778\ud504\ub77c, \uace0\uac00\uce58 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc758 \ud61c\ud0dd\uc744 \ubc1b\uc2b5\ub2c8\ub2e4. \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\uc640\uc758 \ubcd1\uc6a9 \uc694\ubc95\uc740 \ubc18\uc751 \uc9c0\uc18d\uc131\uc744 \ud5a5\uc0c1\uc2dc\ucf1c \uc554 \ubc31\uc2e0\uc774 \uc804\uccb4 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc5d0 \uae30\uc5ec\ud558\ub294 \ubc14\ub97c \uacf5\uace0\ud788 \ud569\ub2c8\ub2e4.<br \/>\n*   \uac10\uc5fc\uc131 \uc9c8\ud658 \uce58\ub8cc\uc81c: 72.2\uc5b5 \ub2ec\ub7ec\ub85c \uaddc\ubaa8\ub294 \uc791\uc9c0\ub9cc, \ub9cc\uc131 B\ud615 \uac04\uc5fc \ubc0f \ud5e4\ub974\ud398\uc2a4 \ud6c4\ubcf4 \ubb3c\uc9c8\uc758 \ubc1c\uc804\uc73c\ub85c 2031\ub144\uae4c\uc9c0 13.06%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc790\uac00\uba74\uc5ed \ubc0f \uc2e0\uacbd\ud559\uc801 \ubc94\uc8fc: \uc544\uc9c1 \ucd08\uae30 \ub2e8\uacc4\uc774\uc9c0\ub9cc \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\uc591\uc131\uc5d0 \uc911\uc694\ud558\uba70, \ub2e4\ubc1c\uc131 \uacbd\ud654\uc99d\uacfc \uac19\uc740 \uc9c8\ubcd1\uc744 \ud45c\uc801\uc73c\ub85c \ud558\ub294 \uc5ed\ubc29\ud5a5 \ubc0f \ub0b4\uc131 \uc720\ub3c4 \ubc31\uc2e0 \uac1c\ubc1c\uc774 \uc9c4\ud589 \uc911\uc785\ub2c8\ub2e4. \ud0c0\uc6b0 \ubc0f \uc54c\ud30c-\uc2dc\ub204\ud074\ub808\uc778 \ubc31\uc2e0\uc744 \ud3ec\ud568\ud55c \uc2e0\uacbd\ud559\uc801 \ud504\ub85c\uc81d\ud2b8\ub294 \uc911\uae30 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc9c4\ud589 \uc911\uc785\ub2c8\ub2e4.<\/p>\n<p>3.2. \uae30\uc220\ubcc4: \ub3d9\uc885 \ud50c\ub7ab\ud3fc\uc774 \uc790\uac00 \ubc31\uc2e0 \uc131\uc7a5\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc9c0\ubc30\uc801<br \/>\n*   \ub3d9\uc885 \ubc31\uc2e0: 2025\ub144 197\uc5b5 \ub2ec\ub7ec(\uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc758 64.72%)\ub97c \uae30\ub85d\ud588\uc73c\uba70, \ud45c\uc900\ud654\ub41c \uae30\uc131\ud488 \ud615\ud0dc\ub85c \uc720\ud1b5\uc774 \uac04\ud3b8\ud569\ub2c8\ub2e4. \uaddc\ubaa8\uc758 \uacbd\uc81c\ub85c \uc778\ud574 \uc6a9\ub7c9\ub2f9 \ube44\uc6a9\uc774 \ub0ae\uace0 \ub85c\ud2b8 \ucd9c\uc2dc\uac00 \ube68\ub77c \ub300\uaddc\ubaa8 \uacf5\uacf5 \uc785\ucc30\uc5d0 \ub9e4\ub825\uc801\uc785\ub2c8\ub2e4.<br \/>\n*   \uc790\uac00 \ubc31\uc2e0: 2031\ub144\uae4c\uc9c0 13.01%\uc758 CAGR\uc744 \uae30\ub85d\ud558\uba70 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc2dc\ud000\uc2f1 \ubc0f \uc81c\uc870 \uc790\ub3d9\ud654\uac00 \ub9ac\ub4dc \ud0c0\uc784\uc744 \ub2e8\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud658\uc790 \ud2b9\uc774\uc801 \uc2e0\uc0dd\ud56d\uc6d0\uc740 \ud2b9\ud788 \uace0\ud615\uc554\uc5d0\uc11c \uc815\ubc00\ub3c4\ub97c \ud5a5\uc0c1\uc2dc\ucf1c \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9\uc744 \uc815\ub2f9\ud654\ud558\ub294 \ub354 \ub192\uc740 \uac1d\uad00\uc801 \ubc18\uc751\ub960\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \ud558\uc774\ube0c\ub9ac\ub4dc \uc544\ud0a4\ud14d\ucc98: \uacf5\uc720 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790 \ucf54\uc5b4\uc640 \uac1c\ubcc4\ud654\ub41c mRNA \uc0bd\uc785\ubb3c\uc744 \uacb0\ud569\ud558\uc5ec \ud655\uc7a5\uc131\uacfc \uac1c\uc778 \ub9de\ucda4\ud654\uc758 \uade0\ud615\uc744 \ub9de\ucda5\ub2c8\ub2e4. AI \uc54c\uace0\ub9ac\uc998\uc774 \uc5d0\ud53c\ud1a0\ud504 \uc120\ud0dd\uc744 \ub354\uc6b1 \uc815\uad50\ud558\uac8c \ud568\uc5d0 \ub530\ub77c \uc790\uac00 \ubc0f &#8220;\ubc18\uac1c\uc778 \ub9de\ucda4\ud615&#8221; \ud615\ud0dc\uac00 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc5d0\uc11c \uc810\uc720\uc728\uc744 \ub192\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>3.3. \uc5f0\ub839\ub300\ubcc4: \uc131\uc778 \uc801\uc6a9\uc774 \ud604\uc7ac \uc218\uc694 \uc8fc\ub3c4<br \/>\n*   \uc131\uc778: 2025\ub144 \ub9e4\ucd9c\uc758 61.88%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc554 \uc720\ubcd1\ub960\uacfc \ub9cc\uc131 \ubc14\uc774\ub7ec\uc2a4 \ubd80\ub2f4\uc774 \uace0\ub839 \uc778\uad6c\uc5d0 \uc9d1\uc911\ub418\uc5b4 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ubcf4\ud5d8 \uc815\ucc45\uc740 \ud3c9\uc0dd \ud56d\ubc14\uc774\ub7ec\uc2a4 \ub610\ub294 \uba74\uc5ed\uc5b5\uc81c \uc694\ubc95\uc744 \uc904\uc774\ub294 \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc744 \uc120\ud638\ud558\uc5ec \uc131\uc778 \ucc44\ud0dd\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc18c\uc544: \uaddc\ubaa8\ub294 \uc791\uc9c0\ub9cc 2031\ub144\uae4c\uc9c0 13.24%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \uc778\uc13c\ud2f0\ube0c, \ud76c\uadc0 \uc9c8\ud658 \uc9d1\uc911, \uc18c\uc544 \uc2e0\uacbd\uad50\uc885\uacfc \uac19\uc740 \uc9c8\ud658\uc5d0 \ub300\ud55c \uba74\uc5ed \uc870\uc808 \uce58\ub8cc\uc5d0 \ub300\ud55c \ubd80\ubaa8\uc758 \uc218\uc6a9 \uc99d\uac00\uac00 \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4.<br \/>\n*   \ub178\uc778 \ub300\uc0c1 \uc81c\ud615: \uba74\uc5ed \ub178\ud654\ub97c \uadf9\ubcf5\ud558\uae30 \uc704\ud55c \uc5f0\uad6c(\uc0ac\uc774\ud1a0\uce74\uc778 \uac15\ud654 LNP, \uace0\uc6a9\ub7c9 \uc694\ubc95)\uac00 \uc9c4\ud589 \uc911\uc774\uba70, OECD \uad6d\uac00\uc5d0\uc11c \uc778\uad6c\uac00 \ub354\uc6b1 \uace0\ub839\ud654\ub428\uc5d0 \ub530\ub77c \uc0c8\ub85c\uc6b4 \uc218\uc694 \uc138\uadf8\uba3c\ud2b8\ub97c \ucc3d\ucd9c\ud560 \uac00\ub2a5\uc131\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3.4. \uc720\ud1b5 \ucc44\ub110\ubcc4: \uacf5\uacf5 \ubd80\ubb38\uc774 \ud1b5\uc81c \uc720\uc9c0<br \/>\n*   \uacf5\uacf5 \ud504\ub85c\uadf8\ub7a8: \uc8fc\ub85c \uc815\ubd80 \ubcf4\uac74 \uc11c\ube44\uc2a4 \ubc0f \ub2e4\uc790\uac04 \uc870\ub2ec \uae30\uad00\uc73c\ub85c, 2025\ub144 \uc6a9\ub7c9\uc758 68.22%\ub97c \ud655\ubcf4\ud588\uc73c\uba70, \uc911\uc559 \uc9d1\uc911\uc2dd \ucf5c\ub4dc\uccb4\uc778 \uc790\uc0b0\uacfc \ub300\ub7c9 \uad6c\ub9e4\ub825\uc744 \ud65c\uc6a9\ud569\ub2c8\ub2e4. B\ud615 \uac04\uc5fc\uacfc \uac19\uc774 \uc720\ubcd1\ub960\uc774 \ub192\uc740 \uc801\uc751\uc99d\uc5d0 \uc911\uc694\ud558\uba70, \uad11\ubc94\uc704\ud55c \uc811\uadfc\uc131\uc774 \uc6a9\ub7c9\ub2f9 \ub0ae\uc740 \uac00\uaca9\uc744 \uc0c1\uc1c4\ud569\ub2c8\ub2e4.<br \/>\n*   \ubbfc\uac04 \uc2dc\uc124: \uc804\ubb38 \uc885\uc591\ud559 \ud074\ub9ac\ub2c9 \ubc0f \uac1c\uc778 \ub9de\ucda4\ud615 \uc758\ud559 \uc13c\ud130\ub97c \ud3ec\ud568\ud558\uba70, \uc790\uac00 \ubc0f \ubcd1\uc6a9 \uc694\ubc95\uc5d0 \uac1c\ubcc4\ud654\ub41c \ubb3c\ub958\uac00 \ud544\uc694\ud568\uc5d0 \ub530\ub77c 2031\ub144\uae4c\uc9c0 12.98%\uc758 CAGR\ub85c \uc131\uc7a5\ud569\ub2c8\ub2e4. \uc7ac\ud0dd \uc8fc\uc785 \uc635\uc158\uc774 \uc5f0\uad6c \uc911\uc774\uba70, \uc720\ud1b5 \ubaa8\ub378\uc758 \ubbf8\ub798 \ub2e4\uac01\ud654\ub97c \uc608\uace0\ud569\ub2c8\ub2e4.<\/p>\n<p>4. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 41.12%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, FDA \ud68d\uae30\uc801 \uc9c0\uc815, \uc9d1\uc911\ub41c \ubca4\ucc98 \uce90\ud53c\ud0c8 \uc790\uae08, \uc2e0\uc18d\ud55c \ub4f1\ub85d \ub124\ud2b8\uc6cc\ud06c\uc758 \uac15\uc810\uc5d0 \ud798\uc785\uc5c8\uc2b5\ub2c8\ub2e4. Project NextGen \ubc0f BARDA \ubcf4\uc870\uae08\uc740 \ubcf4\uc2a4\ud134\uc5d0\uc11c \uc0cc\ub514\uc5d0\uc774\uace0\uc5d0 \uc774\ub974\ub294 \ud559\uc220-\uc0b0\uc5c5 \ud5c8\ube0c\ub97c \uc9c0\uc6d0\ud558\uba70, \uba38\ud06c\uc758 10\uc5b5 \ub2ec\ub7ec \ub354\ub7fc \uacf5\uc7a5 \ubc0f \ud654\uc774\uc790\uc758 4\uc5b5 6,500\ub9cc \ub2ec\ub7ec \uce7c\ub77c\ub9c8\uc8fc \uc5c5\uadf8\ub808\uc774\ub4dc\uc640 \uac19\uc740 \ud655\uc7a5\uc740 \uc789\uc5ec \ucda9\uc804-\ub9c8\uac10(fill-finish) \uc6a9\ub7c9\uc744 \ucc3d\ucd9c\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \uc0c1\ub2f9\ud55c \uacf5\uacf5-\ubbfc\uac04 \ucee8\uc18c\uc2dc\uc5c4\uacfc Horizon Europe \ubcf4\uc870\uae08\uc774 \uc911\uac1c \uc5f0\uad6c\ub97c \uc774\ub04c\uace0 \uc788\uc2b5\ub2c8\ub2e4. EMA\uc758 PRIME \ubc0f \uc870\uac74\ubd80 \uc2b9\uc778 \ud504\ub85c\uadf8\ub7a8\uc740 \ub3c5\uc77c\uacfc \ud504\ub791\uc2a4\uc758 \uac00\uce58 \uae30\ubc18 \uac00\uaca9 \ucc45\uc815 \ud30c\uc77c\ub7ff\uacfc \uc77c\uce58\ud558\uc5ec \ub192\uc740 \uc218\uc694 \uc801\uc751\uc99d\uc5d0 \ub300\ud55c \uc870\uae30 \uc2dc\uc7a5 \uc9c4\uc785\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. WACKER\uc758 \ud560\ub808 mRNA \uc13c\ud130\uc640 \uac19\uc740 \uc2dc\uc124\uc740 \ub300\ub959\uc758 \uacf5\uae09 \ubcf4\uc548\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 13.22%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc911\uad6d\uc758 \uaddc\uc81c \ud604\ub300\ud654\uc640 \uc81c\uc870 \ube44\uc6a9 \uc6b0\uc704\uac00 \ud575\uc2ec\uc785\ub2c8\ub2e4. \ud604\uc9c0 \ubc14\uc774\uc624\ud14d \uae30\uc5c5\ub4e4\uc740 \ud2b9\ud5c8 \uc5f0\uacc4\ub97c \ud65c\uc6a9\ud558\uc5ec \uc11c\uad6c \uae30\uc5c5\uacfc \uacf5\ub3d9 \uac1c\ubc1c\ud558\uba70, \uc2f1\uac00\ud3ec\ub974\uc640 \ud55c\uad6d\uc758 \uc0c8\ub85c\uc6b4 CDMO \ucea0\ud37c\uc2a4\ub294 \uae00\ub85c\ubc8c \uace0\uac1d\uc5d0\uac8c \uacf5\uae09\ud569\ub2c8\ub2e4. \uc77c\ubcf8\uc758 \uace0\ub839\ud654 \uc778\uad6c\uc640 \uc885\uc591\ud559 \uce58\ub8cc\uc5d0 \ub300\ud55c \ud504\ub9ac\ubbf8\uc5c4 \ubcf4\ud5d8 \uc801\uc6a9\uc740 \ub2e8\uc704 \uac00\uaca9\uc744 \ub192\uc5ec \ub290\ub9b0 \ubb3c\ub7c9 \uc99d\uac00\ub97c \uc0c1\uc1c4\ud569\ub2c8\ub2e4.<\/p>\n<p>5. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \ud30c\ud3b8\ud654\ub41c \uc2dc\uc7a5\uc73c\ub85c, \uc0c1\uc704 5\uac1c \uae30\uc5c5\uc774 2024\ub144 \ub9e4\ucd9c\uc758 \uc57d 45%\ub97c \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uba38\ud06c, GSK, \ud654\uc774\uc790 \ub4f1 \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \ud50c\ub7ab\ud3fc \ubc14\uc774\uc624\ud14d \uae30\uc5c5\ub4e4\uacfc mRNA \ubc0f \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uacf5\ub3d9 \uac1c\ubc1c\ud558\uba70, \ub9c8\uc77c\uc2a4\ud1a4 \uc9c0\uae09\uacfc \ud558\ub958 \uc218\uc775 \ubd84\ud560\uc744 \uad50\ud658\ud569\ub2c8\ub2e4. \uc218\uc9c1 \ud1b5\ud569\uc774 \uc2ec\ud654\ub418\uc5b4 \uae30\uc5c5\ub4e4\uc740 \uc9c0\uc9c8 \ub098\ub178\uc785\uc790(LNP) IP\ub97c \ud655\ubcf4\ud558\uace0, \ud50c\ub77c\uc2a4\ubbf8\ub4dc \uacf5\uae09\uc744 \ud655\ubcf4\ud558\uba70, \uc804\ubb38 CDMO\ub97c \uc778\uc218\ud558\uc5ec \ub9c8\uc9c4\uc744 \ubcf4\ud638\ud558\uace0 \uc218\uc694 \uae09\uc99d \uc2dc \uc2ac\ub86f \uac00\uc6a9\uc131\uc744 \ubcf4\uc7a5\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubc14\uc774\uc624\ud14d \uc804\ubb38 \uae30\uc5c5\ub4e4\uc740 \ub3c5\uc810\uc801\uc778 \ud56d\uc6d0 \uc120\ud0dd \uc54c\uace0\ub9ac\uc998\uacfc \uc804\uae30\ucc9c\uacf5 \ud328\uce58\uc640 \uac19\uc740 \uc7a5\uce58 \ubcf4\uc870 \uc804\ub2ec\uc744 \ud1b5\ud574 \ucc28\ubcc4\ud654\ud569\ub2c8\ub2e4. AI \uae30\ubc18 \uc2e0\uc0dd \uae30\uc5c5\ub4e4\uc740 \uc9c4\ub2e8 \uae30\uc5c5\uacfc \uc870\uae30\uc5d0 \ud611\ub825\ud558\uc5ec \ubc31\uc2e0\uc744 \uc885\uc591 \ub3cc\uc5f0\ubcc0\uc774 \ubd80\ub2f4\uc5d0 \ub9de\ucdb0 \ud3ec\uad04\uc801\uc778 \uce58\ub8cc \uc0dd\ud0dc\uacc4\ub97c \uad6c\ucd95\ud569\ub2c8\ub2e4. \ud55c\ud3b8, \ud559\uc220 \uc2a4\ud540\uc544\uc6c3 \uae30\uc5c5\ub4e4\uc740 \uc0c8\ub85c\uc6b4 \ubcf4\uc870\uc81c \ud654\ud559 \ubb3c\uc9c8\uc744 \uacf5\uae09\ud558\uba70, \uc885\uc885 \ub300\ud615 \uc81c\uc57d\uc0ac\uc5d0 \uae00\ub85c\ubc8c \uc720\ud1b5\uc744 \uc704\ud574 \ub77c\uc774\uc120\uc2a4\ub97c \ubd80\uc5ec\ud569\ub2c8\ub2e4. 2025\ub144 \ubc29\uad11\uc554 \uce58\ub8cc\ub97c \uc704\ud55c BCG\uc640 \ubcd1\uc6a9\ud558\ub294 Anktiva\uc758 FDA \uc2b9\uc778\uc740 \uc2dc\ub108\uc9c0 \ud6a8\uacfc\ub97c \ub0b4\ub294 \uc694\ubc95\uc744 \uac80\uc99d\ud558\uc5ec \uae30\uc5c5 \uac04 \uc81c\ud734\ub97c \uc7a5\ub824\ud569\ub2c8\ub2e4.<\/p>\n<p>\uac00\uaca9 \uacb0\uc815\ub825\uc740 \uc801\uc751\uc99d\uc5d0 \ub530\ub77c \ub2e4\ub985\ub2c8\ub2e4. \uc885\uc591\ud559\uc740 \ud504\ub9ac\ubbf8\uc5c4 \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ubc1b\uc9c0\ub9cc, \uac10\uc5fc\uc131 \uc9c8\ud658 \uce58\ub8cc\uc81c\ub294 \ubb3c\ub7c9\uc5d0 \uc758\uc874\ud569\ub2c8\ub2e4. \ub530\ub77c\uc11c \uae30\uc5c5\ub4e4\uc740 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\uc758 \uade0\ud615\uc744 \ub9de\ucdb0 \ud604\uae08 \ud750\ub984 \uc548\uc815\uc131\uc744 \uc720\uc9c0\ud558\uba74\uc11c \uace0\uc704\ud5d8, \uace0\uc218\uc775 \uac1c\uc778 \ub9de\ucda4\ud615 \ud504\ub85c\uadf8\ub7a8\uc744 \ucd94\uad6c\ud569\ub2c8\ub2e4. \uae30\uc220 \uaca9\ucc28\ub97c \uba54\uc6b0\uace0 \uc81c\uc870 \ub178\ub4dc\ub97c \ud1b5\ud569\ud558\uae30 \uc704\ud55c \uc9c0\uc18d\uc801\uc778 M&#038;A\uac00 \uc608\uc0c1\ub418\uba70, 2030\ub144\uae4c\uc9c0 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc758 \uc9d1\uc911\ub3c4\uac00 \ub192\uc544\uc9c8 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>6. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 4\uc6d4: \uc601\uad6d\uc5d0\uc11c \uc9c4\ud589\uc131 \ud53c\ubd80\uc554 \ud658\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \ubc14\ub298 \uc5c6\ub294 DNA \ubc31\uc2e0 iSCIB1+\uc758 \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc2dc\uc791\ub418\uc5c8\uc73c\uba70, \uc774\ub294 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \ud3c9\uac00\ub97c \uac00\uc18d\ud654\ud558\ub294 NHS \ud504\ub85c\uadf8\ub7a8\uc758 \uc77c\ud658\uc785\ub2c8\ub2e4.<br \/>\n*   2025\ub144 3\uc6d4: \uba38\ud06c\ub294 \ud655\uc7a5\ub418\ub294 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uc9c0\uc6d0\ud558\uae30 \uc704\ud574 \uc804\uc6a9 \ubc31\uc2e0 \uc0dd\uc0b0 \uc2dc\uc124\uc744 \uac1c\uc124\ud558\uc5ec \uc5c5\uacc4 \uc804\ubc18\uc758 \uc81c\uc57d\uc744 \uc644\ud654\ud558\uae30 \uc704\ud55c \uc5ed\ub7c9\uc744 \ucd94\uac00\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 6\uc6d4: WACKER\ub294 \ub3c5\uc77c \ud560\ub808\uc5d0 mRNA \uc5ed\ub7c9 \uc13c\ud130\ub97c \uac1c\uc124\ud558\uace0 1\uc5b5 \uc720\ub85c \uc774\uc0c1\uc744 \ud22c\uc790\ud558\uc5ec \uc5f0\uac04 2\uc5b5 \ud68c\ubd84 \uc774\uc0c1\uc758 \uc0dd\uc0b0\ub7c9\uc744 \uac00\ub2a5\ud558\uac8c \ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 2\uc6d4: \ud5ec\ub984\ud640\uce20 \ubb8c\ud5e8\uacfc \ud30c\ud2b8\ub108\ub4e4\uc740 \ub9cc\uc131 B\ud615 \uac04\uc5fc\uc744 \ud45c\uc801\uc73c\ub85c \ud558\ub294 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 TherVacB\uc758 \uc548\uc804\uc131\uacfc \uba74\uc5ed\uc6d0\uc131\uc744 \ud3c9\uac00\ud558\uae30 \uc704\ud55c 1\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uac74\uac15\ud55c \uc790\uc6d0\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uac10\uc5fc \ub610\ub294 \uc9c8\ubcd1 \ubc1c\uc0dd \ud6c4 \ud56d\ubc14\uc774\ub7ec\uc2a4 \uba74\uc5ed\uc744 \uc720\ub3c4\ud558\uace0 \uc9c8\ubcd1\uc758 \uacbd\uacfc\ub97c \ubcc0\ud654\uc2dc\ud0a4\uae30 \uc704\ud574 \uc801\uc6a9\ub418\ub294 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uce58\ub8cc\uc6a9 \ubc31\uc2e0\uc740 \ubbf8\ub798 \uc9c8\ubcd1 \uc608\ubc29\uc744 \uc704\ud55c \uba74\uc5ed\ud654\ubcf4\ub2e4\ub294 \ud658\uc790 \uc790\uc2e0\uc758 \uba74\uc5ed \uccb4\uacc4\ub97c \ud65c\uc6a9\ud558\uc5ec \uac10\uc5fc\uacfc \uc2f8\uc6b0\ub294 \ubc29\uc2dd\uc73c\ub85c \uc9c8\ubcd1\uc744 \uce58\ub8cc\ud558\ub294 \ub370 \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ubc94\uc704\ub294 \uc81c\ud488(\uc790\uac00\uba74\uc5ed \uc9c8\ud658 \ubc31\uc2e0, \uc2e0\uacbd\ud559\uc801 \uc9c8\ud658 \ubc31\uc2e0, \uc554 \ubc31\uc2e0, \uac10\uc5fc\uc131 \uc9c8\ud658 \ubc31\uc2e0 \ubc0f \uae30\ud0c0 \uc81c\ud488), \uae30\uc220(\ub3d9\uc885 \ubc31\uc2e0 \ubc0f \uc790\uac00 \ubc31\uc2e0), \uc5f0\ub839\ub300(\uc131\uc778, \uc18c\uc544, \ub178\uc778), \uc720\ud1b5 \ucc44\ub110(\uacf5\uacf5, \ubbfc\uac04) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc73c\uba70, \uc804 \uc138\uacc4 \uc8fc\uc694 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \ub3d9\ud5a5\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2dc\uc7a5\uc740 2026\ub144 342.2\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 614.8\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778:<br \/>\n\ub9cc\uc131 \ubc0f \uac10\uc5fc\uc131 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \ubc31\uc2e0 R&#038;D\uc5d0 \ub300\ud55c \uc815\ubd80 \uc790\uae08 \uc9c0\uc6d0 \uac15\ud654, \uc81c\uc57d\/\ubc14\uc774\uc624 \uae30\uc5c5\uc758 \ud56d\uc554 \ubc31\uc2e0 \ud30c\uc774\ud504\ub77c\uc778 \ud655\ub300, \ud68d\uae30\uc801\uc778 mRNA \uae30\ubc18 \uce58\ub8cc\uc6a9 \ubc31\uc2e0 \uc2b9\uc778, AI \uae30\ubc18 \uc2e0\ud56d\uc6d0 \ubc1c\uacac\uc744 \ud1b5\ud55c \uac1c\uc778 \ub9de\ucda4\ud654 \uac00\uc18d\ud654, \ud604\uc7a5 \ubaa8\ub4c8\ud615 \ub9c8\uc774\ud06c\ub85c \ud329\ud1a0\ub9ac \uc81c\uc870 \ubaa8\ub378 \ub3c4\uc785 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<br \/>\n\uc790\ubcf8 \uc9d1\uc57d\uc801\uc774\uace0 \uc704\ud5d8 \ubd80\ub2f4\uc774 \ud070 \uc784\uc0c1 \uac1c\ubc1c \uc8fc\uae30, \ub2e4\uad6d\uc801\uc758 \uc5c4\uaca9\ud55c \uaddc\uc81c \uc7a5\ubcbd, GMP \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\/\ud50c\ub77c\uc2a4\ubbf8\ub4dc \uc81c\uc870 \uc5ed\ub7c9 \ubd80\uc871, \ud6c4\uae30 \uba74\uc5ed\ud56d\uc554\uc81c \uc784\uc0c1 \uc2e4\ud328\ub85c \uc778\ud55c \ud22c\uc790 \uc2ec\ub9ac \uc704\ucd95 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\ubd80 \uc2dc\uc7a5 \ubd84\uc11d:<br \/>\n*   \uc81c\ud488\ubcc4: \uc554 \ubc31\uc2e0\uc740 \uac15\ub825\ud55c \uc784\uc0c1\uc801 \uc720\ud6a8\uc131\uacfc \ub192\uc740 \uc885\uc591\ud559 \uc218\uc694\uc5d0 \ud798\uc785\uc5b4 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728 42.63%\ub85c \uac00\uc7a5 \ud070 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uae30\uc220\ubcc4: \ub3d9\uc885(Allogeneic) \ud50c\ub7ab\ud3fc\uc774 2025\ub144 \ub9e4\ucd9c\uc758 64.72%\ub97c \ucc28\uc9c0\ud558\uba70 \uc6b0\uc704\ub97c \uc810\ud558\uace0 \uc788\uc73c\ub098, \uc790\uac00(Autologous) \ubc31\uc2e0\uc740 13.01%\uc758 \ub354 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc744 \ubcf4\uc774\uba70 \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc81c\uc870 \uc774\uc810\uacfc \uaddc\uc81c \ud604\ub300\ud654\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 13.22%\uc758 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc815\ubd80\uc758 \uc601\ud5a5 \ubc0f \uc8fc\uc694 \uacfc\uc81c:<br \/>\n\ubbf8\uad6d \uc815\ubd80\uc758 50\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 &#8216;\ud504\ub85c\uc81d\ud2b8 \ub125\uc2a4\ud2b8\uc820(Project NextGen)&#8217;\uacfc \uac19\uc740 \ud504\ub85c\uadf8\ub7a8\uc740 \ucc28\uc138\ub300 \ud50c\ub7ab\ud3fc\uc5d0 \uc790\uae08\uc744 \uc9c0\uc6d0\ud558\uc5ec \ucd08\uae30 \ub2e8\uacc4\uc758 \uc704\ud5d8\uc744 \ub0ae\ucd94\uace0 \uc0c1\uc5c5\ud654\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ub192\uc740 \uc790\ubcf8 \uc694\uad6c \uc0ac\ud56d, \ubcf5\uc7a1\ud55c \ub2e4\uc9c0\uc5ed \uaddc\uc81c, \uc81c\ud55c\uc801\uc778 GMP \ubca1\ud130 \uc0dd\uc0b0 \ub2a5\ub825\uc740 \ub2e8\uae30\uc801\uc778 \uc131\uc7a5 \uc804\ub9dd\uc744 \uacc4\uc18d \uc81c\ud55c\ud558\ub294 \uc8fc\uc694 \uacfc\uc81c\ub85c \ub0a8\uc544 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f Agenus Inc., GlaxoSmithKline plc, Merck &#038; Co., Inc., Novartis AG, Pfizer Inc., BioNTech SE, Moderna, Inc., Sanofi SA \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud558\uc5ec \uacbd\uc7c1 \ud658\uacbd\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \ubbf8\uac1c\ucc99 \uc2dc\uc7a5 \ubc0f \ucda9\uc871\ub418\uc9c0 \uc54a\uc740 \uc694\uad6c \uc0ac\ud56d\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \ud1b5\ud574 \ud5a5\ud6c4 \uc2dc\uc7a5 \uae30\ud68c\ub97c \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-36958","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/36958"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=36958"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/36958\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=36958"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=36958"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=36958"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}